Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rivastigmine Toxicity”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)Looking for participantsNCT06382649
What this trial is testing

Rivastigmine for Antimuscarinic Delirium

Who this might be right for
Anticholinergic Toxicity
Washington University School of Medicine 42
Testing effectiveness (Phase 2)Temporarily pausedNCT06399679
What this trial is testing

Rivastigmine to Prevent Recurrence of Antimuscarinic Delirium

Who this might be right for
Anticholinergic Toxicity
Washington University School of Medicine 42
Post-approval studies (Phase 4)Study completedNCT07545382
What this trial is testing

Rivastigmine as an Antidote for Clozapine-induced Central Nervous System Depression and Delirium

Who this might be right for
Anticholinergic DeliriumClozapine PoisoningAntipsychotic Toxicity+4 more
Alexandria University 100
Not applicableStudy completedNCT00624663
What this trial is testing

A Double-Blind, Placebo-controlled Crossover Study of Repeat Rivastigmine Administration in Healthy Male Volunteers

Who this might be right for
Rivastigmine Toxicity
Tel-Aviv Sourasky Medical Center 15